top of page
Our Vision
Pioneering the Future of Cancer Treatment with Effective, Durable and Accessible T and NK Cell Therapy
Our Mission
Develop transformative platform technology to generate next-generation T/NK cell therapies with superior potency and durability – driving long-lasting clinical responses
Our company
Sakura Bio is an innovative biotech company aiming to transform the future of cell therapy with effective, durable, and accessible T and NK cell treatments.
Our core technology, T-Boost, reprograms T and NK cells during the manufacturing process to enhance potency, persistence, and resistance to the tumor microenvironment—addressing critical limitations of current CAR-T and other cell therapies.
PUBLICATION
Publication
bottom of page